What are the major opportunities in the Lumbosacral Radicular Pain Management market? What are the strategies for the Lumbosacral Radicular Pain Management market?

For detailed insights on the major opportunities and strategies in the Lumbosacral Radicular Pain Management market, Read More

How does the Lumbosacral Radicular Pain Management market relate to the overall economy and other similar markets?

For detailed insights on Lumbosacral Radicular Pain Management's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Lumbosacral Radicular Pain Management market growth? SWOT analysis of the Lumbosacral Radicular Pain Management market.

For detailed insights on the key dynamics influencing the Lumbosacral Radicular Pain Management market growth and SWOT analysis of the Lumbosacral Radicular Pain Management industry, Read More

Global Lumbosacral Radicular Pain Management Market Report 2025

Item added to cart!

Published : December 2025

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Lumbosacral Radicular Pain Management Global Market Report 2025

Name: Lumbosacral Radicular Pain Management Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Medication (Non-Steroidal Anti-Inflammatory Drugs, Opioids, Antidepressants, Anticonvulsants, Steroids), By Physical Therapy (Manual Therapy, Exercise Therapy, Electrotherapy, Thermal Therapy, Hydrotherapy), By Route Of Administration (Oral, Topical), By End-User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Lumbosacral Radicular Pain Management Market?

Lumbosacral radicular pain management refers to the comprehensive approach to diagnosing, treating, and relieving pain that originates from irritation or compression of the spinal nerve roots in the lumbosacral region (lower back and sacral area). It is commonly associated with conditions such as herniated discs, spinal stenosis, or degenerative disc disease. Management focuses on easing inflammation, decompressing the affected nerves, and promoting functional recovery. The primary objective is to enhance mobility, minimize pain, and improve the patient’s overall quality of life.

The main types of lumbosacral radicular pain management medications are non-steroidal anti-inflammatory drugs, opioids, antidepressants, anticonvulsants, and steroids. NSAIDs are widely used as a first-line treatment to reduce inflammation and relieve pain in lumbosacral radicular conditions by inhibiting inflammation-causing enzymes. It is treated with several physical therapies, such as manual therapy, exercise therapy, electrotherapy, thermal therapy, and hydrotherapy, and is administered through several routes of administration, such as oral and topical, and is used by various end-users, including hospital pharmacies, retail pharmacies, and online pharmacies.

Lumbosacral Radicular Pain Management Market Size and growth rate 2025 to 2029: Graph

What Is The Lumbosacral Radicular Pain Management Market Size 2025 And Growth Rate?

The lumbosacral radicular pain management market size has grown strongly in recent years. It will grow from $0.85 billion in 2024 to $0.9 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to the growing prevalence of lumbar disc herniation, increasing awareness about spinal disorders, a rising geriatric population, advances in diagnostic imaging techniques, and the expanding use of non-invasive pain management therapies.

What Is The Lumbosacral Radicular Pain Management Market Growth Forecast?

The lumbosacral radicular pain management market size is expected to see strong growth in the next few years. It will grow to $1.11 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to innovation in minimally invasive surgical techniques, rising adoption of biologic therapies, increasing focus on personalized pain management, growing demand for outpatient pain clinics, and integration of digital health and telemedicine in pain management. Major trends in the forecast period include advancements in minimally invasive spine surgeries, advancements in neurostimulation devices, biologic therapies like platelet-rich plasma, AI-driven diagnostics and personalized treatment plans, and the development of novel non-opioid analgesics.

Book your 30 minutes free consultation with our research experts

How Is The Lumbosacral Radicular Pain Management Market Segmented?

The lumbosacral radicular pain management market covered in this report is segmented –

1) By Medication: Non-Steroidal Anti-Inflammatory Drugs, Opioids, Antidepressants, Anticonvulsants, Steroids

2) By Physical Therapy: Manual Therapy, Exercise Therapy, Electrotherapy, Thermal Therapy, Hydrotherapy

3) By Route Of Administration: Oral, Topical

4) By End-User: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Non-Steroidal Anti-Inflammatory Drugs: Ibuprofen, Naproxen, Diclofenac, Celecoxib, Etoricoxib

2) By Opioids: Tramadol, Oxycodone, Morphine, Hydrocodone, Fentanyl

3) By Antidepressants: Amitriptyline, Nortriptyline, Duloxetine, Desvenlafaxine, Venlafaxine

4) By Anticonvulsants: Gabapentin, Pregabalin, Carbamazepine, Lamotrigine, Topiramate

5) By Steroids: Dexamethasone, Methylprednisolone, Prednisone, Triamcinolone, Hydrocortison

What Is Driving The Lumbosacral Radicular Pain Management Market? The Rising Prevalence Of Back Pain Disorders Is Fueling The Growth Of The Market Due To Increasing Sedentary Lifestyles And The Resulting Need For Effective Lumbosacral Radicular Pain Management

The rising prevalence of back pain disorders is expected to propel the growth of the lumbosacral radicular pain management market going forward. Back pain disorders refer to a range of conditions that affect the spine, muscles, or nerves in the back, causing discomfort or pain. The rising prevalence of back pain disorders is due to sedentary lifestyles, which weaken back muscles, causing poor posture and persistent pain. Lumbosacral radicular pain management aims to relieve nerve root irritation in the lower back, reducing pain and inflammation. It restores mobility and improves quality of life. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in 2022, over half (52%) of all hospitalizations for back problems were attributed to back or spine pain where lower back pain accounted for the largest share at 27%, followed by neck pain at 6.2% and radiculopathy at 6.0%. Further, back problems had risen to become the third leading contributor to the overall health burden, representing 4.3% of the total in 2023. Therefore, the rising prevalence of back pain disorders drives the growth of the lumbosacral radicular pain management market.

Who Are The Major Players In The Global Lumbosacral Radicular Pain Management Market?

Major companies operating in the lumbosacral radicular pain management market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb, AstraZeneca plc, Novartis AG, GSK plc, Medtronic plc, Eli Lilly and Company, Amgen Inc, Koninklijke Philips NV, Stryker Corporation, Teva Pharmaceutical Industries Ltd, Boston Scientific Corporation, Dr Reddy’s Laboratories Ltd, NuVasive Inc., Nobel Biocare Holdings AG, Ultradent Products Inc., Nevro Corp., Zynex Inc., Eliem Therapeutics, Vertebral Technologies Inc., Semnur Pharmaceuticals Inc.

What Are The Key Trends Of The Global Lumbosacral Radicular Pain Management Market? Advancement Of Non-Opioid Therapies Targeting Nav1.8 For Lumbosacral Radicular Pain Relief

Major companies operating in the lumbosacral radicular pain management market are focusing on developing advanced treatments, such as investigational oral NaV1.8 pain signal inhibitors, to offer a non-opioid alternative for long-lasting pain relief. An investigational oral NaV1.8 pain signal inhibitor is a trial-stage medication that targets the NaV1.8 sodium channel, a key pathway for transmitting pain through sensory nerves. For instance, in December 2024, Vertex Pharmaceuticals, a US-based biotech company, announced results from its Phase 2 study of suzetrigine for painful lumbosacral radiculopathy (LSR). The study met its primary endpoint, showing a statistically significant and clinically meaningful reduction in pain from baseline in the suzetrigine group. Suzetrigine was generally well tolerated, with no serious adverse events reported. Vertex plans to address the high placebo response in future Phase 3 trials to assess the drug’s efficacy better.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Lumbosacral Radicular Pain Management Market? Stryker Corporation Acquired Vertos Medical To Strengthen Chronic Lower Back Pain Solutions

In October 2024, Stryker Corporation, a US-based medical technology company, acquired Vertos Medical Inc. for an undisclosed amount. With this acquisition, Stryker aims to enhance its interventional pain management portfolio, expand its presence in ambulatory surgery centers, and strengthen its offerings in minimally invasive treatments for chronic lower back pain. Vertos Medical Inc. is a US-based company specializing in interventional pain management solutions for the minimally invasive mild procedure for treating lumbar spinal stenosis.

What Is The Regional Outlook For The Global Lumbosacral Radicular Pain Management Market?

North America was the largest region in the lumbosacral radicular pain management market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lumbosacral radicular pain management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lumbosacral radicular pain management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Lumbosacral Radicular Pain Management Market?

The lumbosacral radicular pain management market consists of revenues earned by entities by providing services such as psychological therapy, surgical intervention, chiropractic care, and pharmacological management. The market value includes the value of related goods sold by the service provider or included within the service offering. The lumbosacral radicular pain management market includes sales of muscle relaxants, epidural steroid injections, and nerve blocks. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Lumbosacral Radicular Pain Management Industry?

The lumbosacral radicular pain management market research report is one of a series of new reports from The Business Research Company that provides lumbosacral radicular pain management market statistics, including the lumbosacral radicular pain management industry global market size, regional shares, competitors with the lumbosacral radicular pain management market share, detailed lumbosacral radicular pain management market segments, market trends, opportunities, and any further data you may need to thrive in the lumbosacral radicular pain management industry. This lumbosacral radicular pain management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Author : Abhilash Pyata

Lumbosacral Radicular Pain Management Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$0.9 billion
Revenue Forecast In 2034	$1.11 billion
Growth Rate	CAGR of 5.5% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The lumbosacral radicular pain management market covered in this report is segmented – 1) By Medication: Non-Steroidal Anti-Inflammatory Drugs, Opioids, Antidepressants, Anticonvulsants, Steroids 2) By Physical Therapy: Manual Therapy, Exercise Therapy, Electrotherapy, Thermal Therapy, Hydrotherapy 3) By Route Of Administration: Oral, Topical 4) By End-User: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy Subsegments: 1) By Non-Steroidal Anti-Inflammatory Drugs: Ibuprofen, Naproxen, Diclofenac, Celecoxib, Etoricoxib 2) By Opioids: Tramadol, Oxycodone, Morphine, Hydrocodone, Fentanyl 3) By Antidepressants: Amitriptyline, Nortriptyline, Duloxetine, Desvenlafaxine, Venlafaxine 4) By Anticonvulsants: Gabapentin, Pregabalin, Carbamazepine, Lamotrigine, Topiramate 5) By Steroids: Dexamethasone, Methylprednisolone, Prednisone, Triamcinolone, Hydrocortison
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb, AstraZeneca plc, Novartis AG, GSK plc, Medtronic plc, Eli Lilly and Company, Amgen Inc, Koninklijke Philips NV, Stryker Corporation, Teva Pharmaceutical Industries Ltd, Boston Scientific Corporation, Dr Reddy’s Laboratories Ltd, NuVasive Inc., Nobel Biocare Holdings AG, Ultradent Products Inc., Nevro Corp., Zynex Inc., Eliem Therapeutics, Vertebral Technologies Inc., Semnur Pharmaceuticals Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Lumbosacral Radicular Pain Management Market Characteristics

3. Lumbosacral Radicular Pain Management Market Trends And Strategies

4. Lumbosacral Radicular Pain Management Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Lumbosacral Radicular Pain Management Growth Analysis And Strategic Analysis Framework

5.1. Global Lumbosacral Radicular Pain Management PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Lumbosacral Radicular Pain Management Market Growth Rate Analysis

5.4. Global Lumbosacral Radicular Pain Management Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Lumbosacral Radicular Pain Management Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Lumbosacral Radicular Pain Management Total Addressable Market (TAM)

6. Lumbosacral Radicular Pain Management Market Segmentation

6.1. Global Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Non-Steroidal Anti-Inflammatory Drugs

Opioids

Antidepressants

Anticonvulsants

Steroids

6.2. Global Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Manual Therapy

Exercise Therapy

Electrotherapy

Thermal Therapy

Hydrotherapy

6.3. Global Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Topical

6.4. Global Lumbosacral Radicular Pain Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

6.5. Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Non-Steroidal Anti-Inflammatory Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Ibuprofen

Naproxen

Diclofenac

Celecoxib

Etoricoxib

6.6. Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Opioids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tramadol

Oxycodone

Morphine

Hydrocodone

Fentanyl

6.7. Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Antidepressants, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Amitriptyline

Nortriptyline

Duloxetine

Desvenlafaxine

Venlafaxine

6.8. Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Anticonvulsants, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gabapentin

Pregabalin

Carbamazepine

Lamotrigine

Topiramate

6.9. Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Steroids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Dexamethasone

Methylprednisolone

Prednisone

Triamcinolone

Hydrocortisone

7. Lumbosacral Radicular Pain Management Market Regional And Country Analysis

7.1. Global Lumbosacral Radicular Pain Management Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Lumbosacral Radicular Pain Management Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lumbosacral Radicular Pain Management Market

8.1. Asia-Pacific Lumbosacral Radicular Pain Management Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lumbosacral Radicular Pain Management Market

9.1. China Lumbosacral Radicular Pain Management Market Overview

9.2. China Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lumbosacral Radicular Pain Management Market

10.1. India Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lumbosacral Radicular Pain Management Market

11.1. Japan Lumbosacral Radicular Pain Management Market Overview

11.2. Japan Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lumbosacral Radicular Pain Management Market

12.1. Australia Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lumbosacral Radicular Pain Management Market

13.1. Indonesia Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lumbosacral Radicular Pain Management Market

14.1. South Korea Lumbosacral Radicular Pain Management Market Overview

14.2. South Korea Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lumbosacral Radicular Pain Management Market

15.1. Western Europe Lumbosacral Radicular Pain Management Market Overview

15.2. Western Europe Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lumbosacral Radicular Pain Management Market

16.1. UK Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lumbosacral Radicular Pain Management Market

17.1. Germany Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lumbosacral Radicular Pain Management Market

18.1. France Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lumbosacral Radicular Pain Management Market

19.1. Italy Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lumbosacral Radicular Pain Management Market

20.1. Spain Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lumbosacral Radicular Pain Management Market

21.1. Eastern Europe Lumbosacral Radicular Pain Management Market Overview

21.2. Eastern Europe Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lumbosacral Radicular Pain Management Market

22.1. Russia Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lumbosacral Radicular Pain Management Market

23.1. North America Lumbosacral Radicular Pain Management Market Overview

23.2. North America Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lumbosacral Radicular Pain Management Market

24.1. USA Lumbosacral Radicular Pain Management Market Overview

24.2. USA Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lumbosacral Radicular Pain Management Market

25.1. Canada Lumbosacral Radicular Pain Management Market Overview

25.2. Canada Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lumbosacral Radicular Pain Management Market

26.1. South America Lumbosacral Radicular Pain Management Market Overview

26.2. South America Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lumbosacral Radicular Pain Management Market

27.1. Brazil Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lumbosacral Radicular Pain Management Market

28.1. Middle East Lumbosacral Radicular Pain Management Market Overview

28.2. Middle East Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lumbosacral Radicular Pain Management Market

29.1. Africa Lumbosacral Radicular Pain Management Market Overview

29.2. Africa Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lumbosacral Radicular Pain Management Market Competitive Landscape And Company Profiles

30.1. Lumbosacral Radicular Pain Management Market Competitive Landscape

30.2. Lumbosacral Radicular Pain Management Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis

31. Lumbosacral Radicular Pain Management Market Other Major And Innovative Companies

31.1. AstraZeneca plc

31.2. Novartis AG

31.3. GSK plc

31.4. Medtronic plc

31.5. Eli Lilly and Company

31.6. Amgen Inc

31.7. Koninklijke Philips NV

31.8. Stryker Corporation

31.9. Teva Pharmaceutical Industries Ltd

31.10. Boston Scientific Corporation

31.11. Dr Reddy’s Laboratories Ltd

31.12. NuVasive Inc.

31.13. Nobel Biocare Holdings AG

31.14. Ultradent Products Inc.

31.15. Nevro Corp.

32. Global Lumbosacral Radicular Pain Management Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lumbosacral Radicular Pain Management Market

34. Recent Developments In The Lumbosacral Radicular Pain Management Market

35. Lumbosacral Radicular Pain Management Market High Potential Countries, Segments and Strategies

35.1 Lumbosacral Radicular Pain Management Market In 2029 - Countries Offering Most New Opportunities

35.2 Lumbosacral Radicular Pain Management Market In 2029 - Segments Offering Most New Opportunities

35.3 Lumbosacral Radicular Pain Management Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Lumbosacral Radicular Pain Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Non-Steroidal Anti-Inflammatory Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Opioids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Antidepressants, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Anticonvulsants, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Steroids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Lumbosacral Radicular Pain Management Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Lumbosacral Radicular Pain Management Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Pfizer Inc. Financial Performance

Table 81: Johnson & Johnson Services Inc. Financial Performance

Table 82: Bayer AG Financial Performance

Table 83: Sanofi SA Financial Performance

Table 84: Bristol-Myers Squibb Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Lumbosacral Radicular Pain Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Non-Steroidal Anti-Inflammatory Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Opioids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Antidepressants, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Anticonvulsants, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Steroids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Lumbosacral Radicular Pain Management Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Lumbosacral Radicular Pain Management Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Pfizer Inc. Financial Performance

Figure 81: Johnson & Johnson Services Inc. Financial Performance

Figure 82: Bayer AG Financial Performance

Figure 83: Sanofi SA Financial Performance

Figure 84: Bristol-Myers Squibb Financial Performance

Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Global Vutrisiran Market Trends: Regional Breakdowns and Strategic Insights

Vyndaqel Outlook 2034: Key Drivers, Trends, and Market Frontiers

Functional Dyspepsia DrugMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Joint Pain Injections Global Market Report 2025 – By Type Of Injection (Steroid Joint Injection, Hyaluronic Acid Injections, Platelet-Rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Other Type Of ...

Topical Pain Relief Global Market Report 2025 – By Type (Prescription Pain Relief, Over-The-Counter (OTC) Pain Relief), By Formulation (Cream, Gel, Spray, Patch, Other Formulations), By Therapeutic (Non-Opioids, Opioids)...

Muscle Pain Treatment Global Market Report 2025 – By Pharmacological Treatment (Analgesics, Muscle Relaxants, Topical Analgesics, Other Pharmacological Treatments), By Non-Pharmacological Treatment (Physical Therapy, Mas...

Neuralgia Treatment Global Market Report 2025 – By Treatment (Drug Based, Surgeries), By Indication (Diabetic Neuropathy, Intercostal Neuralgia, Occipital Neuralgia, Peripheral Neuralgia, Postherpetic Neuralgia), By Dist...

Chronic Pain Global Market Report 2025 – By Product (Drug, Devices ), By Indication (Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications), By End User (Hospitals, C...

Analgesics Global Market Report 2025 – By Type (Non-opioids, Opioids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores), By Application (Internal Analgesics, External Analgesics) – Impact of ...

Neurotrophic Keratitis Treatment Global Market Report 2025 – By Treatment (Topical Antibiotics, Recombinant Human Nerve Growth Factor (rhNGF), Amniotic Membrane Transplantation, Keratoplasty, Other Treatments), By Route ...

Frequently Asked Questions

What is the definition of the Lumbosacral Radicular Pain Management market?

How will the Lumbosacral Radicular Pain Management market drivers and restraints affect the market dynamics? What forces will shape the Lumbosacral Radicular Pain Management industry going forward?

The Lumbosacral Radicular Pain Management market major growth driver - The Rising Prevalence Of Back Pain Disorders Is Fueling The Growth Of The Market Due To Increasing Sedentary Lifestyles And The Resulting Need For Effective Lumbosacral Radicular Pain Management. For further insights on the Lumbosacral Radicular Pain Management market, request a sample here

What is the forecast market size or the forecast market value of the Lumbosacral Radicular Pain Management market?

The Lumbosacral Radicular Pain Management market size has grown strongly in recent years. The lumbosacral radicular pain management market size has grown strongly in recent years. It will grow from $0.85 billion in 2024 to $0.9 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to the growing prevalence of lumbar disc herniation, increasing awareness about spinal disorders, a rising geriatric population, advances in diagnostic imaging techniques, and the expanding use of non-invasive pain management therapies. The lumbosacral radicular pain management market size is expected to see strong growth in the next few years. It will grow to $1.11 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to innovation in minimally invasive surgical techniques, rising adoption of biologic therapies, increasing focus on personalized pain management, growing demand for outpatient pain clinics, and integration of digital health and telemedicine in pain management. Major trends in the forecast period include advancements in minimally invasive spine surgeries, advancements in neurostimulation devices, biologic therapies like platelet-rich plasma, AI-driven diagnostics and personalized treatment plans, and the development of novel non-opioid analgesics. For further insights on the Lumbosacral Radicular Pain Management market, request a sample here

How is the Lumbosacral Radicular Pain Management market segmented?

The lumbosacral radicular pain management market covered in this report is segmented –
1) By Medication: Non-Steroidal Anti-Inflammatory Drugs, Opioids, Antidepressants, Anticonvulsants, Steroids
2) By Physical Therapy: Manual Therapy, Exercise Therapy, Electrotherapy, Thermal Therapy, Hydrotherapy
3) By Route Of Administration: Oral, Topical
4) By End-User: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:
1) By Non-Steroidal Anti-Inflammatory Drugs: Ibuprofen, Naproxen, Diclofenac, Celecoxib, Etoricoxib
2) By Opioids: Tramadol, Oxycodone, Morphine, Hydrocodone, Fentanyl
3) By Antidepressants: Amitriptyline, Nortriptyline, Duloxetine, Desvenlafaxine, Venlafaxine
4) By Anticonvulsants: Gabapentin, Pregabalin, Carbamazepine, Lamotrigine, Topiramate
5) By Steroids: Dexamethasone, Methylprednisolone, Prednisone, Triamcinolone, Hydrocortison For further insights on the Lumbosacral Radicular Pain Management market, request a sample here

Which region has the largest share of the Lumbosacral Radicular Pain Management market? What are the other regions covered in the report?

Who are the major players in the Lumbosacral Radicular Pain Management market?

What are the key trends in the Lumbosacral Radicular Pain Management market?

Major trends in the Lumbosacral Radicular Pain Management market include Advancement Of Non-Opioid Therapies Targeting Nav1.8 For Lumbosacral Radicular Pain Relief. For further insights on the Lumbosacral Radicular Pain Management market, request a sample here.